Update: Common Shingrix Reactions--Which Can Be Prevented?
Feb 1, 2019 · Before you administer Shingrix, CDC recommends counseling your patients about the common reactions to the vaccine. You should tell patients to expect such reactions as pain, swelling, and redness ...
Treatment Plan in Patient With Shingles and Inactive TB - Medscape
Jan 13, 2006 · Assessing Treatment Plan in Patient With Outbreak of Shingles and Inactive Tuberculosis. A 22-year-old woman presented with an outbreak of shingles. She had received medication for 6 months for ...
Novel Treatment Alleviates Postherpetic Neuralgia - Medscape
Oct 7, 2024 · Crisugabalin — an oral calcium channel alpha 2 delta-1 subunit ligand — was safe and well-tolerated at doses of 40 mg/d and 80 mg/d and significantly reduced pain scores in patients with ...
Newer Shingles Vaccine Tied to Lower Dementia Risk - Medscape
July 25, 2024. 0. Receipt of a newer recombinant version of a shingles vaccine is associated with a significant delay in dementia diagnosis in older adults, a new study suggests. The study builds ...
Shingles Vaccine Offers 4 Years of Protection - Medscape
Jan 11, 2024 · Two doses of the recombinant zoster vaccine (RZV) are effective against herpes zoster (HZ) for 4 years after vaccination, according to a new study published in the Annals of Internal Medicine ...
TNF Inhibitors May Increase Shingles Risk - Medscape
Feb 18, 2009 · Shingles is a neurocutaneous disease that results from the reactivation of the varicella-zoster virus. It is characterized by a painful vesicular dermatomal rash. Herpes zoster is one of the most ...
Optimal Management of Perianal Disease in Crohn's Disease
Aug 29, 2024 · Upadacitinib is a JAK inhibitor, a newer medication, that has been shown to be effective for refractory disease. ... No. Crohn's patients in general are at risk for shingles, ...
Updated Perioperative Guidance Says When to Hold …
Mar 4, 2022 · The new advice is to withhold the drugs for 1 week after last dose prior to surgery. New recommendations offer the same advice for belimumab, both IV and subcutaneous: Withhold for 1 week after ...
Gabapentin Plus Valacyclovir Effective for Management of
Mar 25, 2003 · Gabapentin Plus Valacyclovir Effective for Management of Acute Zoster Pain. March 25, 2003 (San Francisco) — Results from an open-label pilot trial of gabapentin with valacyclovir given within ...
5 Things to Know When Prescribing Topical Antifungals - Medscape
Jul 2, 2024 · Here are five things to know when prescribing or recommending topical antifungals. 1. Visual diagnosis of superficial fungal infections is often incorrect. Superficial fungal infections frequently ...